# FDA Inspection 1277270 - Surmasis Pharmaceutical, LLC - August 01, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/surmasis-pharmaceutical-llc/5fb29e39-e823-41b8-9d3c-db716adf874c
Source feed: FDA_Inspections

> FDA Inspection 1277270 for Surmasis Pharmaceutical, LLC on August 01, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277270
- Company Name: Surmasis Pharmaceutical, LLC
- Inspection Date: 2025-08-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Kansas City District Office

## Related Documents

- [FDA Inspection 1121169 - 2020-03-19](https://www.globalkeysolutions.net/records/fda_inspections/surmasis-pharmaceutical-llc/9af114b0-9b1f-4a65-9868-a647531d81f8)
- [FDA Inspection 1042777 - 2018-03-01](https://www.globalkeysolutions.net/records/fda_inspections/surmasis-pharmaceutical-llc/2e115b4e-ec8a-4fdd-905a-b99b8dc377af)

Company: https://www.globalkeysolutions.net/companies/surmasis-pharmaceutical-llc/6f9dfe3c-c8c3-4740-b9a8-0ecc1bb9b400

Office: https://www.globalkeysolutions.net/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79